Press Releases Archives

Press Releases

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

May 8, 2020

A New and Cost-Effective Tool to Combat the E-cigarette Epidemic Among Youth ACTON, MA, May 5, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in…

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

April 29, 2020

admin

Blog Posts, Press Releases

A New and Cost-Effective Tool to Detect and Deter Nicotine use ACTON, MA, April 29, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting…

Psychemedics Test for Fentanyl Detection Cleared by FDA

April 25, 2019

Psychemedics

Blog Posts, Press Releases

Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, MA, April 24, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse…

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

April 25, 2019

Psychemedics

Press Releases

Acton, MA, April 23, 2019 — Psychemedics Corporation (NASDAQ:PMD) today announced first-quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18…

New Psychemedics Offering Further Enhances Cocaine Detection

March 27, 2019

admin

Press Releases

Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader in detecting drugs…

Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

September 26, 2017

Psychemedics

Press Releases

In another first, the world’s largest hair drug testing company & scientific leader launches new test for Benzodiazepines Acton, Massachusetts, September 26, 2017 – Psychemedics Corporation (NASDAQ:PMD), hair testing pioneer…

Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

August 22, 2017

Psychemedics

Press Releases, Uncategorized

World’s largest hair drug testing company & scientific leader launches new tool for combatting rising Synthetic Cannabinoids (K2, Spice) abuse Acton, Massachusetts, August 22, 2017– Psychemedics Corporation (NASDAQ:PMD), hair testing…

Psychemedics Corporation – First Lab Approved For Hair Testing in Iowa

August 22, 2017

Psychemedics

Press Releases

Acton, MA, August 16, 2017 — Psychemedics Corporation (NASDAQ:PMD) today announced it has become the first laboratory to be approved for the testing of drugs of abuse in hair by…

Psychemedics Corporation Announces 2017 Q2 Earnings

August 2, 2017

Psychemedics

Press Releases

Psychemedics 2017 Q2 Earnings ACTON, Mass., Aug. 2, 2017,/PRNewswire/ — Psychemedics Corporation (NASDAQ: PMD) today announced second-quarter financial results for the period ended June 30, 2017. The Company also…

Psychemedics Corporation Responds To Recent Price Volatility

January 31, 2017

Psychemedics

Press Releases, Uncategorized

Acton, Massachusetts, January 31, 2017 — Psychemedics Corporation (NASDAQ:PMD) today announced that recent volatility in its stock price on January 31, 2017 appears to have been caused by a news…

Press Releases

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

Psychemedics Test for Fentanyl Detection Cleared by FDA

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

New Psychemedics Offering Further Enhances Cocaine Detection

Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

Psychemedics Corporation – First Lab Approved For Hair Testing in Iowa

Psychemedics Corporation Announces 2017 Q2 Earnings

Psychemedics Corporation Responds To Recent Price Volatility

Recent Posts

Categories

Archives